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Abstract
Fish and PUFA consumption are thought to play a role in mental health; however, many studies do not take into account multiple sources
of PUFA. The present study analysed data from a sample of 935 randomly selected, population-based women aged 20–93 years. A vali-
dated and comprehensive dietary questionnaire ascertained the consumption of n-3 and n-6 PUFA. Another assessed fish and energy intake
and provided data for a dietary quality score. The General Health Questionnaire-12 (GHQ-12) measured psychological symptoms and a
clinical interview (Structured Clinical Interview for DSM-IV-TR Research Version, Non-patient edition) assessed depressive and anxiety dis-
orders. Median dietary intakes of long-chain n-3 fatty acids (310 mg/d) were below suggested dietary target levels. The only PUFA related
to categorical depressive and anxiety disorders was DHA. There was a non-linear relationship between DHA intake and depression; those
in the second tertile of DHA intake were nearly 70 % less likely to report a current depressive disorder compared to those in the first tertile.
The relationship of DHA to anxiety disorders was linear; for those in the highest tertile of DHA intake, the odds for anxiety disorders were
reduced by nearly 50 % after adjustments, including adjustment for diet quality scores, compared to the lowest tertile. Those who ate fish
less than once per week had higher GHQ-12 scores, and this relationship was particularly obvious in smokers. These are the first obser-
vational data to indicate a role for DHA in anxiety disorders, but suggest that the relationship between DHA and depressive disorders may
be non-linear.
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Linoleic acid (LA; 18 : 2n-6) and a-linolenic acid (ALA;
18 : 3n-3) are considered essential PUFA, in that they cannot
be created by the body and must be consumed in the
diet(1). LA is predominantly derived from vegetable oils,
such as sesame, cottonseed and sunflower oils, whereas ALA
is largely derived from plant foods such as walnuts, veg-
etables, legumes, grains and rapeseed oil(2). These PUFA are
synthesised endogenously to create the main long-chain
(LC) n-6 PUFA, arachidonic acid (AA; 20 : 4n-6), the LC n-3
PUFA EPA (20 : 5n-3), docosapentaenoic acid (DPA; 22 : 5n-3)
and DHA (22 : 6n-3), although the conversion of LA to AA is
far more efficient than that of ALA to EPA and DHA(3). The
LC-PUFA can also be obtained directly from the diet; fish
and seafood are the major dietary sources of EPA and DHA.
Recently, it has been established that beef and lamb, which
are usually grass-fed in Australia, are also an important
source of n-3 PUFA in the Australian diet, contributing
nearly half of the average intake of LC n-3 PUFA in the form
of DPA(4).
Several lines of evidence indicate that a relationship exists
between n-3 and n-6 PUFA and mental health. For example,
numerous studies in clinical populations have demonstrated
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reduced levels of n-3 PUFA and increased ratios of n-6:n-3 in
patients with major depression compared to healthy con-
trols(5–9). However, trials of LC n-3 PUFA supplementation
in depression have yielded equivocal results. A very recent
meta-analysis determined that there was a very small ben-
eficial effect of treatment with n-3 compared to placebo, but
that the benefit of supplementation was only observable in
those with clinical depression, in particular those with more
severe depression(10). It was concluded that increased n-3
PUFA consumption, via fish intake or supplementation,
would be of little benefit to the general population. Nonethe-
less, in several population studies, low levels of fish and/or
n-3 PUFA consumption are associated with increased
depression(11–16), although a linear relationship has not
always been observed(17–20).
Previous studies in this field have concentrated on the diet-
ary intakes of fish and/or n-3 PUFA EPA and DHA, and have
not additionally measured DPA, n-6 PUFA or n-3 PUFA from
vegetable sources such as nuts and seeds. Moreover, most
studies have not accounted for overall energy intake, which
may confound or obscure the relationship between PUFA
and mental health(21). Furthermore, most, but not all(16), pre-
vious studies failed to examine measures of overall diet quality
as a confounding factor in the relationship between PUFA/fish
consumption and mental health(22). Finally, there are no exist-
ing observational studies of the relationship between dietary
intakes of PUFA and anxiety disorders which, together with
depression, comprise the common mental disorders. In the
present study, we aimed to examine the associations between
the consumption of both vegetable and animal sources of n-3
and n-6 PUFA, fish consumption and clinically determined
depressive and anxiety disorders, as well as psychological
symptoms, in a randomly selected, population-based sample
of adult women. We further aimed to test overall diet quality
as an explanatory variable in any relationship of fish and/or
PUFA intake to mental health outcomes.
Methods
Participants
The Geelong Osteoporosis Study is a large epidemiological
study involving women selected from compulsory Australian
Commonwealth electoral rolls for the Barwon Statistical
Division. An age-stratified, randomly selected, population-
based sample of women (aged 20–94 years) was recruited
between 1994 and 1997, with a minimum of 100 in each
5-year age stratum between the ages of 20 and 69 years, and
a minimum of 200 in the 70–79-year age group and in the
over 80-year age group, with an original participation rate
of 77·1 %. Reasons for non-participation included death,
migration from the region, inability to give informed consent,
pregnancy or inability to be contacted. In order to afford
continuing investigation of the full adult age range, an
additional sample of 200 women aged between the ages of
20 and 29 years was recruited in 2004–2008, with a response
of 70·9 %. These women have continued to return for
biennial follow-up assessments(23). Of the 1127 women who
participated in the Geelong Osteoporosis Study 10-year
follow-up, participants for whom psychiatric or PUFA data
were not available (n 192) were excluded from the study,
resulting in a sample of 935 women aged 20–93 years avail-
able for analysis. The present study was conducted according
to the guidelines laid down in the Declaration of Helsinki, and
the Barwon Health Human Research Ethics Committee
approved all procedures involving human subjects. Written
informed consent was obtained from all participants.
Dietary assessment
Habitual diet quality, fish consumption and energy intake
were assessed with the Cancer Council dietary question-
naire(24). This is a comprehensive optically scannable FFQ,
validated for assessing habitual dietary intake in the Australian
population(25). This FFQ asked participants to report their
usual consumption of seventy-four foods and six alcoholic
beverages over the preceding 12 months using a ten-point
frequency scale. Using the estimated portions sizes, intakes
of each food were converted to daily equivalents for statistical
analyses. Nutrient intakes, including energy, were computed
from the FFQ data using an in-house program, developed
by the Cancer Council Victoria using NUTTAB95(26) nutrient
composition data.
PUFA FFQ
The semi-quantitative PUFA FFQ is a validated electronic
questionnaire designed to assess main food sources of n-3
and n-6 PUFA(27). The PUFA FFQ consisted of thirty-eight
questions regarding the usual dietary habits related to PUFA
intake over the previous 3 months. The questions were
specific to food items that are animal sources of PUFA, such
as fish, meat and eggs, and plant sources of PUFA, including
vegetable oils, nuts and seeds. Categories of food included
breads/cereals, fish/seafood, meat, eggs, nuts and desserts.
Fish oil capsule consumption was also ascertained by the
questionnaire, as well as products with enriched LC n-3
such as bread, eggs and milk. Questions regarding the
frequency of consumption included several choices, ranging
from never to intakes per d, week or month.
Diet quality score
An a priori diet quality score (DQS) was derived from
the Cancer Council FFQ, based on the Australian national
guidelines for healthy eating(28) and on an algorithm pre-
viously validated in Australian women(29). This scoring
method assigned points for the consumption of desirable
foods at the recommended levels; for example, a point was
assigned for the consumption of at least two fruit serves
per d; at least five serves of vegetables per d; red meat
consumption more than once, but less than five times per
week; using low-fat dairy products; using high-fibre, whole-
meal, rye or multigrain breads, etc. In addition, a maximum
of two points were assigned for alcohol consumption at
the recommended levels(30).


















The Structured Clinical Interview for DSM-IV-TR Research Ver-
sion, Non-patient edition (SCID-I/NP)(31) was the primary
diagnostic instrument for the common mental disorders. This
is the ‘gold-standard’ assessment tool comprising a validated,
semi-structured clinical interview for the major Axis I psychia-
tric disorders in DSM-IV-TR. Diagnoses of current major
depressive disorder, dysthymia and anxiety disorders (panic
disorder, agoraphobia, social phobia, specific phobia, obses-
sive-compulsive disorder, generalised anxiety disorder,
anxiety disorders due to a general medical condition, sub-
stance-induced anxiety disorders and anxiety disorders not
otherwise specified) were the outcomes of interest of the pre-
sent study. Researchers trained in psychology and adminis-
tration of the SCID-I/NP conducted these interviews.
Psychological symptoms were measured with the self-
reported General Health Questionnaire-12 (GHQ-12)(32).
Covariates
Socio-economic status (SES) was determined using Socio-
economic Index For Areas index scores based on the 2006
Australian Bureau of Statistics census data. It was decided
a priori to use the Index of Relative Socio-economic Advantage
and Disadvantage, which accounts for high and low income
and the type of occupation from unskilled employment to
professional positions. A low score on this index identifies
the most disadvantaged (quintile 1) and a high score identifies
the most advantaged (quintile 5). Physical activity was assessed
by self-report questionnaire and ranged from (1) chair or bed-
ridden or limited activity throughout the home through to (4)
very active. Alcohol consumption in g/d was ascertained from
the dietary questionnaire and was subsequently categorised
according to 2001 recommendations for women(30) as the
following: zero consumption (1), one to fourteen standard
drinks per week (2) and fifteen or more standard drinks per
week (3). Current cigarette smoking (yes/no) was self-reported.
Energy intake (kJ/d) was determined from the FFQ. Height was
measured to the nearest 0·1 cm and body weight was measured
to the nearest 0·1 kg. BMI was calculated from these measure-
ments as weight/height2 (kg/m2).
Statistical analysis
Differences in characteristics and dietary intakes between
those with and without categorical diagnoses on the SCID-I/
NP were tested using t tests, Mann–Whitney tests or the
x 2 test. DQS were normally distributed; however, all PUFA
variables and GHQ-12 scores were positively skewed. PUFA
intakes could not be transformed and were thus categorised
into tertiles, which allowed for an examination of non-linear
relationships. Fish in g/d and GHQ-12 scores were normalised
using natural log transformations, standardised using z-scores
and subsequently expressed as standard deviation units.
Frequency of fish consumption was also examined, with the
dichotomous variable classified as fish consumption once a
week or more, compared to fish consumption less than
once per week.
Multivariable linear regression analyses were used to assess
the relationship of the exposure variables of interest and
GHQ-12 scores. Logistic regression models were developed
to estimate OR with 95 % CI using current major depressive
disorder/dysthymia and anxiety disorders as the outcomes of
interest. PUFA and fish consumption, in both g/d and as a
dichotomous frequency variable, were the exposure variables
of interest. For each analysis, the following covariates were
entered sequentially in order to test their contribution to the
mental health outcomes: age, SES, health behaviours (physical
activity, alcohol consumption and smoking), energy intake
and, finally, DQS. BMI and antidepressant use were also
tested in the models as explanatory variables. Smoking, anti-
depressant use and BMI (,25 or $25) kg/m2) were tested
as effect modifiers.
There were no missing data on dietary variables. There
were missing data for GHQ-12 scores (n 21) and list-wise
exclusions were used when GHQ-12 was the outcome vari-
able, resulting in a sample of 914 women for these analyses.
There were twenty-five participants with missing data on
BMI. There were no missing data on any other variables.
Results
Dietary intakes
Median dietary intakes of AA were 140 mg/d. Those of LA
were 6·7 g/d (interquartile range (IQR) 5·0–9·8) and of ALA
were 0·95 g/d (IQR 0·55–1·25), which were comparable to
the adequate intake of 8 and 0·8 g/d, respectively, for Austra-
lian women(1). Median intakes of the n-3 PUFA EPA, DHA and
DPA were 310 mg/d (IQR 210–480 mg/d), which exceeds the
adequate intake of 90 mg/d for Australian women, but falls
short of the suggested dietary target of 430 mg/d. The National
Health and Medical Research Council (NHMRC) definition of
adequate intake is based on mean/median population
intakes(33) and not on physiological need, whereas the
suggested dietary target is defined as ‘the daily average
intake from food and beverages for certain nutrients that
may help in prevention of chronic disease’(1). DQS were nor-
mally distributed (mean 31 (SD 8·5)), while GHQ-12 scores
were slightly positively skewed (median 22, IQR 20–25).
Slightly more than half of the participants (51 %) consumed
fish once or more per week.
Characteristics of those with and without categorical diag-
noses on the SCID-1/NP are given in Table 1. There were
fifty-one (5·5 %) individuals with current depressive disorders
and sixty-six (7·1 %) with current anxiety disorders. There
were thirty-four women (3·6 %) with depressive disorders
only; forty-nine women (5·2 %) with only anxiety disorders;
and seventeen women (1·8 %) with both. Those with current
anxiety disorders were younger than those without, while
those with a current depressive disorder were more likely to
smoke than those without. Otherwise, there were no differ-
ences between groups on Socio-economic Index For Areas
scores, physical activity, alcohol or energy intake and BMI.

















There were no significant differences between those with and
without current depressive and/or anxiety disorders in any of
the PUFA or fish consumption variables (Table 2).
Categorical diagnoses
In multivariable analyses examining PUFA and depressive and
anxiety disorders, the only identified confounders were
energy intake and DQS, and all logistic regression analyses
were adjusted for these variables. There were no relationships
observed between the frequency of fish consumption or fish
in g/d and either depressive or anxiety disorders (data not
shown). Moreover, there were no relationships detected
among the intakes of LA, AA, ALA, EPA or DPA or ratios of
n-6:n-3 and depressive and/or anxiety disorders. The only
apparent relationships observed were between intakes of
DHA and anxiety and depressive disorders (Table 3.) For
those in the highest tertile of DHA intake, the odds for anxiety
disorders were reduced by nearly half compared to the lowest
tertile, and the relationship between the variables was linear
(P for trend¼0·045). In contrast, the relationship between
DHA intake and depressive disorders was non-linear. For
those in the second tertile of DHA intake, the odds for current
depression were reduced by nearly 70 % compared to the
Table 2. PUFA and fish intakes: comparisons between those with and without depressive/anxiety disorders









Median IQR Median IQR P Median IQR Median IQR P
PUFA (g/d)
LA 7·3 4·7–10·7 6·7 5·0–9·8 0·99 6·2 4·4–10·8 6·8 5·0–9·8 0·62
AA 0·15 0·10–0·24 0·14 0·10–0·20 0·63 0·14 0·08–0·17 0·14 0·10–0·20 0·15
ALA 0·85 0·56–1·33 0·77 0·55–1·25 0·72 0·72 0·52–1·06 0·78 0·55–1·27 0·29
EPA 0·11 0·05–0·18 0·09 0·06–0·14 0·65 0·08 0·05–0·12 0·09 0·06–0·14 0·07
DPA 0·08 0·05–0·13 0·08 0·05–0·11 0·74 0·07 0·05–0·11 0·08 0·06–0·12 0·18
DHA 0·14 0·07–0·26 0·13 0·08–0·22 0·75 0·13 0·06–0·18 0·13 0·08–0·26 0·11
LC-n-3 total 0·36 0·17–0·54 0·31 0·21–0·48 0·74 0·29 0·18–0·41 0·31 0·21–0·49 0·15
n-3 Total 1·36 0·86–1·67 1·18 0·86–1·70 0·34 1·11 0·87–1·52 1·20 0·86–1·72 0·24
n-6 Total 7·6 4·9–11·2 7·1 5·3–10·1 0·82 6·6 4·7–11·0 7·1 5·3–10·1 0·54
Total PUFA 8·6 6·0–12·6 8·5 6·3–12·1 0·74 8·0 5·8–12·4 8·5 6·3–12·1 0·45
n-6:n-3 5·3 4·1–8·3 6·0 4·4–8·0 0·64 6·6 4·3–9·2 5·9 4·4–7·9 0·24
Fish (g/d) 29 10–57 31 16–57 0·66 32 5–61 31 16–57 0·33
MDD, major depressive disorder; LA, linoleic acid; AA, arachidonic acid; ALA, a-linolenic acid; DPA, docosapentaenoic acid; LC, long-chain.
Table 1. Characteristics of study sample: comparisons between those with and without depressive/anxiety disorders









n % n % P n % n % P
Age (years) 0·73 0·05
Mean 50·7 51·9 47·4 52·2
SD 12·9 19·1 16·0 18·9
BMI (kg/m2) 0·20 0·94
Mean 28·0 27·3 27·2 27·4 0·94
SD 5·2 5·7 5·6 5·7
Smoking (current) 11 21·6 104 11·8 0·04 11 16·7 104 12·0 0·26
Physical activity
(active or very active)
35 68·6 695 78·6 0·46 46 69·7 684 78·7 0·21
Energy (kJ/d) 0·60 0·28
Mean 6935·8 6634·0 6804·1 6638·8
SD 2928·4 2255·9 2223·0 2303·1
SES (1 ¼ low)
1 8 15·7 136 15·4 0·79 8 12·1 136 15·7 0·43
2 8 15·7 186 21·0 11 16·7 183 21·1
3 14 27·5 202 22·9 15 22·7 201 23·1
4 12 23·5 175 19·8 19 28·8 168 19·3
5 9 17·6 185 20·9 13 19·7 181 20·8
Alcohol (drinks/week)
0 13 25·5 169 19·1 0·34 14 21·2 168 19·3 0·85
1–14 29 56·9 591 66·9 44 66·7 576 66·3
15þ 9 17·6 124 14·0 8 12·1 125 14·4
Fish oil supplement use 12 23·5 133 15·0 0·10 14 21·2 131 15·1 0·18
MDD, major depressive disorder; SES, socio-economic status.

















lowest tertile, while those in the highest tertile, the likelihood
was equivalent to those in the lowest. Median intakes for DHA
in the first tertile were 65 (IQR 48–80) mg/d, in the second tertile
were 134 (IQR 111–156) mg/d, while median intakes for the
highest tertile were 272 (IQR 223–377) mg/d. Further analyses
revealed that women with major depressive disorder/dysthymia
or anxiety disorders tended to be more likely to take n-3
supplements than women with no disorder (major depressive
disorder/dysthymia 23·5 v. 15·0 %, P¼0·10; anxiety disorders
21·2 v. 15·1 %, P¼0·18); however, adjustment for supplement
use (yes/no) did not substantially alter the shape or strength of
the observed relationships (data not shown).
General Health Questionnaire-12 scores
We observed a trend towards a relationship between the
intake of DHA and GHQ-12 scores after adjustments for age,
SES, physical activity, alcohol consumption and energy
intake (compared to lowest tertile of DHA intake, tertile 2:
z-scored b ¼ 20·16, 95 % CI 20·32, 0·004; tertile 3: z-scored
b ¼ 20·15, 95 % CI 20·31, 0·02); however, this relationship
was fully explained by adjustments for DQS. There were no
relationships between the dietary intakes of any of the other
PUFA and GHQ-12 scores (all P.0·10). Smoking was ident-
ified as an effect modifier in the relationship between fish
intake and GHQ-12 scores, and these analyses were thus
split by smoking status (yes/no). Before and after adjustments
for age, SES, physical activity, alcohol consumption and
energy intake, the dietary intake of fish in g/d tended to be
inversely related to GHQ-12 scores for both smokers and
non-smokers, but the relationship was stronger in smokers.
However, these relationships were also fully explained by
final adjustment for DQS. In analyses examining frequency
of fish intake, we report that for those women consuming
fish once per week or more, there was a 0·16 SD decrease in
GHQ-12 scores for non-smokers and a 0·52 SD decrease for
smokers compared to those consuming fish less than once
per week after adjustments for age, SES, physical activity, alco-
hol consumption and energy intake (Table 4). This relation-
ship was attenuated by adjustment for DQS in non-smokers,
but remained significant in smokers. Neither antidepressant
use nor BMI was identified as a confounder or effect modifier
in any analyses.
Discussion
In the present cross-sectional, community-based study in
women, we report inverse, linear relationships between the
dietary consumption of DHA and the likelihood of anxiety dis-
orders, and a non-linear relationship between DHA intake and
depressive disorders. We also observed a relationship between
an increased frequency of fish consumption and reduced
psychological symptoms, which was stronger in smokers.
However, we failed to detect relationships between any
other PUFA and these mental health parameters.
To our knowledge, the present study is the first observa-
tional study to report an association between the dietary
intakes of PUFA and clinically determined anxiety disorders.
However, there is some clinical and experimental evidence
supporting these findings. A case–control investigation of
twenty-seven untreated, non-depressed patients with social
anxiety disorder reported significantly reduced levels of
most n-3 PUFA in erythrocytes compared to healthy con-
trols(34), while in an experimental study, administration of
Table 3. Results of multivariable logistic regression analyses*





OR 95 % CI OR 95 % CI
LA
Lowest (ref) 1 1
2 0·53 0·25, 1·12 0·76 0·40, 1·46
3 0·84 0·42, 1·70 1·10 0·59, 2·07
AA
Lowest (ref) 1 1
2 0·69 0·33, 1·45 1·27 0·71, 2·28
3 0·94 0·47, 1·89 0·55 0·27, 1·23
ALA
Lowest (ref) 1 1
2 0·82 0·39, 1·69 0·83 0·45, 1·53
3 1·03 0·51, 2·08 0·71 0·37, 1·34
EPA
Lowest (ref) 1 1
2 0·80 0·37, 1·71 0·74 0·40, 1·38
3 1·31 0·64, 2·69 0·62 0·32, 1·21
DPA
Lowest (ref) 1 1
2 0·76 0·38, 1·55 0·90 0·50, 1·65
3 0·77 0·37, 1·57 0·67 0·35, 1·30
DHA
Lowest (ref) 1 1
2 0·31 0·12, 0·79 0·78 0·43, 1·42
3 1·44 0·73, 2·83 0·49 0·24, 0·98
MDD, major depressive disorder; LA, linoleic acid; ref, reference; AA, arachidonic
acid; ALA, a-linolenic acid; DPA, docosapentaenoic acid.
* Depressive and anxiety disorders, adjusted for adjusted for energy intake and diet
quality score.
Table 4. Fish intake and General Health Questionnaire-12 (GHQ-12)
scores split by smokers/non-smokers
(b-Coefficients and 95 % confidence intervals)
GHQ-12 scores (z-scored)
b-Coefficient 95 % CI P
Fish (g/d)
Smokers (n 114)
* 20·17 20·37, 0·03 0·10
þDQS 20·14 20·37, 0·03 0·19
Non-smokers (n 800)
* 20·06 20·14, 0·01 0·09
þDQS 20·03 20·12, 0·06 0·53
Fish $once per week
Smokers (n 114)
* 20·52 20·92, 20·12 0·01
þDQS 20·49 20·91, 20·07 0·02
Non-smokers (n 800)
* 20·16 20·30, 20·02 0·03
þDQS 20·10 20·25, 0·05 0·17
DQS, diet quality score.
* Adjusted for age, BMI, Socio-economic Index for Areas scores, physical activity,
alcohol consumption and energy intake.

















ethyl-EPA attenuated stress- and anxiety-like behaviours in
rodents(35). There are also data from two small randomised,
placebo-controlled trials in human subjects. Buydens-
Branchey & Branchey(36) trialled an EPA/DHA supplement
v. placebo in twenty-four men being treated for substance
use. They found a significant reduction in symptoms of anxiety
over a 3-month treatment period in the intervention group, and
this was maintained for a further 3 months after treatment
discontinuation. Another study investigated the impact of
DHA supplementation v. placebo on fifty-three healthy, non-
smoking college students over a 3-month examination period.
They reported that measures of stress and aggression increased
in the placebo group over this period, whereas those in the
intervention group remained stable, suggesting that DHA sup-
plementation may attenuate the stress response in adults(37).
The present findings regarding a non-linear association
between DHA consumption and depression and psychological
symptoms are concordant with some other observational and
intervention studies. Sanchez-Villegas et al.(20) also failed to
detect a linear relationship between LC n-3 PUFA consump-
tion and mental illnesses in the Seguimiento Universidad de
Navarra (SUN) Cohort Study. In their study, it was the third
and fourth quintiles of energy-adjusted EPA and DHA con-
sumption, with median intakes for each quintile of 0·87 and
1·17 g/d, respectively, that demonstrated a reduction in the
risk for depression, anxiety and stress over 2 years of
follow-up. Those in the highest quintile, with median intakes
of 1·89 g/d, showed no reduction in risk. Further support for a
biphasic association between DHA and depression is offered
by a recent clinical trial, wherein thirty-five depressed adult
outpatients with depression were randomised into one of
three double-blind dosing arms for 12 weeks. Those receiving
1 g/d of DHA showed the greatest improvement in symptoms
(83 %), the group receiving 2 g/d improved by 40 %, while the
group receiving the highest dose showed no improvement(38).
In the present study, women with a depressive or anxiety dis-
order were slightly more likely to take n-3 supplements, but
this did not explain the observed relationships.
Our observation of an association between frequency of fish
intake and psychological symptoms in women is also concor-
dant with many population-based studies previously pub-
lished. For example, a study of 5689 adults in Finland(11)
reported that women who rarely ate fish were up to 2·5
times more likely to report depression than regular fish
eaters. The risk for suicidal ideation was also increased by
1·5-fold for women who were infrequent fish eaters. However,
no such relationships were seen in males. In another cross-
sectional Finnish study of 3204 adults, the odds of reporting
depressive symptoms were increased by a third for infrequent
fish eaters compared to frequent fish eaters(12). When the ana-
lyses were split by sex, the association was again significant in
women, but not in men. Colangelo et al.(13) also found an
inverse relationship between the dietary intake of fish and
n-3 PUFA and chronic depression in women, but not
men. In contrast, a recent study in adolescents identified a
relationship between higher intakes of fish, EPA and DHA
and a lower prevalence of depressive symptoms in males,
but not females(39). In a community study of 4644 adults in
New Zealand, non-fish consumers scored significantly lower
on self-reported mental health measures than fish consumers,
and the authors noted that consumption of fish less than once
a month appeared to be sufficient for improved self-reported
mental health status(14). Similarly, Bountziouka et al.(15)
reported that the consumption of at least one fish meal per
week was associated with a reduced likelihood of self-reported
depression in older adults. Appleton et al.(16) also reported
inverse associations between the dietary intake of fish and
depressed mood in men participating in the Prospective
Epidemiological Study of Myocardial Infarction (PRIME), but
found that this relationship was confounded by age and social
deprivation in another study of population-based adults(17).
The present results suggest that fish consumption may play
a role in reducing mental health symptoms. This may be the
case or it may be that fish is protective only as a component
of a healthy dietary pattern. Most previous studies have not
examined diet quality as a confounder in the relationship
between fish consumption and depression, and it is plausible
to posit that a healthy diet, characterised by a multitude of
nutrients that may be important to mental health (e.g. Jacka
et al.(22,40–42)), is the explanatory factor in the relationships
observed. In the present study, diet quality explained the
association between fish consumption and psychological
symptoms in non-smokers, but did not fully explain the
relationship in smokers.
The stronger association that we observed between fish
consumption and psychological symptoms in smokers is con-
sistent with another study in women. Sontrop et al.(43)
reported an inverse relationship between intakes of n-3
PUFA and depression only in pregnant women who were
smokers and/or single, but not in other pregnant women.
The association of fish or n-3 PUFA consumption and mental
health is likely to be related to deficiency states only. In sup-
port of this contention are previous data indicating a non-
linear association between fish consumption and depression;
lower intakes of fish being initially associated with depressed
mood, but as the intake of fish increases, the relationship with
mood is attenuated(16,17). The stronger association we
observed between fish intake and psychological symptoms
in smokers is suggestive of the idea that in an environment
of increased oxidative stress, fish consumption may be particu-
larly protective. Smoking increases oxidative stress and is
known to cause lipid peroxidation(44), which may reduce
levels of n-3 PUFA in tissues. In the present study, the inverse
association between fish consumption and psychological
symptoms in smokers was particularly clear for those in the
lowest quintile of fish consumption (data not shown). On
the other hand, a large, longitudinal study of the association
among dietary intake of fish, n-3 PUFA from fish and low
mood, major depression and suicide(18) reported no associ-
ations between the variables of interest in a population-
based survey of 29 133 middle-aged Finnish male smokers.
Strengths and limitations
These findings are limited by the constraints of a cross-
sectional study design, which precludes any determination

















regarding the direction of the relationships. Appetite changes
and/or biased reporting as a function of psychological status
may have influenced the dietary intakes recorded in the pre-
sent study. Moreover, residual confounding by socio-econ-
omic and/or behavioural factors, or unrecognised
confounding by factors such as personality traits, are all poten-
tial explanations for the present findings. These may also be
chance findings, given the number of exposure variables
and tests performed. On the other hand, the use of a detailed
and validated questionnaire designed to assess vegetable as
well as animal sources of PUFA, the assessment of depressive
and anxiety disorders using a ‘gold standard’ tool and the
representative nature of our sample(23), which was randomly
selected and encompassed the full adult age range, are all
important strengths in the present study.
In conclusion, we observed no relationships among the
dietary intake of LA, ALA, AA, EPA or DPA and psychological
symptoms, depressive and/or anxiety disorders. However, we
have reported a non-linear relationship between DHA intake
and depressive disorders, a linear relationship between
lower consumption of DHA and an increased likelihood of
clinically determined anxiety disorders, and a relationship
between infrequent fish consumption and increased psycho-
logical symptoms in smokers, none of which was confounded
by overall dietary quality. These are the first observational data
to indicate a role for DHA in anxiety disorders, but suggest
that the relationship between DHA and depressive disorders
may be non-linear. They also suggest that regular fish con-
sumption may be of particular importance to smokers. Further
research should now examine the potential of DHA as a treat-
ment strategy in anxiety and focus on determining the optimal
level of DHA intake in the prevention and treatment of
depression.
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